mechan
viral
spike
protein
mediat
initi
stage
membran
fusion
fairli
well
understood
number
virus
current
three
class
viral
fusion
protein
recogn
although
structur
unrel
viral
fusion
protein
class
refold
establish
conform
bring
fusion
peptid
transmembran
domain
tmd
close
proxim
thu
initi
membran
fusion
initi
stage
viral
membran
fusion
includ
refold
spike
protein
wellunderstood
exact
mechan
membran
merg
remain
unclear
like
transmembran
domain
tmd
amino
acid
residu
adjac
tmd
viral
fusion
protein
play
role
process
instanc
influenza
ha
molecul
anchor
membran
gpi
anchor
stead
wild
type
tmd
unabl
complet
fusion
process
rather
membran
fusion
halt
hemifus
stage
addit
shown
glycin
residu
tmd
vesicular
stomat
viru
glycoprotein
vsvg
play
critic
role
membran
fusion
furthermor
shown
membraneproxim
domain
fusion
protein
human
immunodefici
viru
import
fusion
activ
particular
aromat
residu
shown
involv
process
fusion
pore
dilat
likewis
palmitoyl
cystein
situat
close
viral
membran
implic
fusion
process
coronaviru
influenza
viru
shown
tmd
coronaviru
spike
protein
also
crucial
membran
fusion
activ
swap
tmd
sever
acut
respiratori
syndrom
coronaviru
sar
cov
spike
vsvg
shown
entri
sar
pseudoparticl
sarspp
sar
cov
spike
protein
mediat
cellcel
fusion
depend
presenc
tmd
spike
tmd
sar
cov
spike
protein
consist
three
domain
highli
conserv
ntermin
aromat
tryptophan
rich
stretch
hydrophob
core
sequenc
ctermin
cystein
rich
domain
domain
highli
conserv
coronavirus
see
figur
paper
describ
extens
mutagenesi
studi
aromat
domain
sar
cov
effect
mutat
entri
fusion
addit
tri
map
amino
acid
actual
membran
introduc
charg
lysin
residu
differ
posit
predict
tmd
region
measur
capac
mutat
spike
protein
mediat
cell
entri
viru
like
particl
use
previous
describ
sarspp
assay
addit
determin
oligomer
state
nonact
mutant
mutant
concern
aromat
domain
analyz
use
fluoresc
dye
transfer
assay
data
present
show
specif
amino
acid
close
tmd
crucial
membran
fusion
activ
sar
cov
previous
aromat
domain
hiv
shown
import
entri
hiv
target
cell
particular
dilat
fusion
pore
recent
howard
et
al
shown
also
aromat
residu
juxtamembran
domain
sar
cov
import
entri
sar
cov
creat
mutant
want
investig
import
aromat
domain
sar
smediat
entri
figur
show
sarspp
contain
longer
capabl
transduc
vero
cell
indic
aromat
domain
essenti
entri
sarspp
moreov
tryptophan
residu
aromat
domain
replac
alanin
sarspp
infecti
either
indic
alanin
take
role
tryptophan
sar
mediat
entri
suggest
crucial
role
tryptophan
residu
sar
mediat
entri
wimley
white
describ
index
membran
interfaci
amino
acid
rank
index
indic
tendenc
amino
acid
particip
interfac
membran
water
tryptophan
score
highest
wwindex
second
rank
phenylalanin
investig
whether
high
interfaci
tryptophan
aromat
domain
import
entrymedi
activ
sar
protein
decid
replac
one
tryptophan
phenylalanin
residu
creat
mutant
figur
show
replac
three
tryptophan
residu
phenylalanin
mutant
result
total
lack
sarspp
entri
also
mutant
protein
contain
two
three
phenylalanin
stead
tryptophan
mutant
capabl
mediat
entri
sarspp
mutant
contain
one
phenylalanin
replac
tryptophan
residu
entrymedi
activ
clearli
show
tryptophan
residu
aromat
domain
sar
play
specif
role
entri
sarspp
taken
phenylalanin
residu
therefor
high
propens
particip
interfac
water
membran
probabl
featur
tryptophan
residu
involv
mediat
sarspp
entri
although
rule
time
exclud
possibl
defect
protein
matur
incorpor
sarspp
aromat
domain
mutant
analyz
trimer
incorpor
effici
mutant
incorpor
effici
sarspp
abl
trimer
figur
tryptophan
play
import
role
mediat
fusion
hiv
membran
target
membran
particular
tryptophan
residu
implic
process
fusion
pore
dilat
ie
enlarg
fusion
pore
exactli
work
poorli
understood
decid
test
sever
mutant
aromat
domain
capac
mediat
cellcel
fusion
induc
fusion
pore
format
particular
experi
decid
use
mutant
aromat
domain
context
delet
cterminu
would
yield
higher
amount
molecul
surfac
cell
therebi
potenti
increas
window
cellcel
fusion
assay
therefor
mutant
creat
use
cellcel
fusion
experi
togeth
swt
control
figur
pictur
shown
syncytia
repres
cultur
induc
mutant
molecul
swt
clearli
induc
round
syncytia
consist
approxim
cell
determin
number
nuclei
abl
induc
much
larger
round
syncytia
least
twice
mani
nuclei
swt
indic
high
concentr
surfac
cell
contrast
syncytia
induc
contain
cell
irregular
shape
compar
swt
induc
syncytia
cell
seem
form
small
group
differ
morpholog
posit
control
indic
cellfus
mediat
activ
alter
rather
cell
seem
stick
togeth
yet
fuse
result
confirm
mix
cell
l
cell
stabli
express
human
transfect
cell
transient
express
mutant
measur
mix
cell
content
l
cell
stain
green
cmfda
invitrogen
cell
stain
red
cmtpx
invitrogen
sinc
dye
unabl
transfer
spontan
one
cell
anoth
costain
cell
measur
cell
fusion
larg
syncytia
stain
posit
dye
form
swt
wherea
costain
observ
indic
lack
fusion
figur
previous
cell
express
aromaticmut
molecul
shown
unabl
induc
syncytium
format
shown
induc
fusion
pore
format
block
dilat
fusion
pore
evidenc
transfer
small
dye
molecul
one
cell
anoth
investig
sar
aromat
mutant
capac
display
similar
activ
ie
induct
fusion
pore
yet
incap
establish
full
cell
fusion
sexpress
cell
label
cmacblu
dye
present
cytoplasm
modifi
cytosol
enzym
make
unabl
transfer
one
cell
anoth
express
cell
label
calcein
transfer
one
cell
anoth
fusion
pore
doubl
fluoresc
cell
thu
repres
transfer
calcein
express
cell
sexpress
cell
therebi
show
exist
fusion
pore
figur
sampl
shown
doubl
fluoresc
cell
clearli
shown
mutant
abl
form
fusion
pore
sinc
show
doubl
fluoresc
cell
shown
figur
suppos
tmd
domain
sar
quit
long
especi
locat
charg
residu
usual
defin
border
tmd
consid
ntermin
lysin
po
locat
aromat
domain
wherea
ctermin
lysin
locat
cy
box
cy
box
po
number
amino
acid
two
lysin
wherea
typic
tmd
consist
approxim
amino
acid
attempt
map
actual
border
tmd
sar
construct
rang
mutant
extra
lysin
residu
introduc
two
previous
mention
lysin
see
figur
idea
introduct
lysin
hydrophob
transmembran
environ
would
result
defect
protein
unabl
establish
fusion
addit
two
posit
insert
lysin
rather
replac
exist
amino
acid
lysin
control
mutant
alanin
stead
introduc
lysin
made
mutant
express
could
incorpor
sarspp
result
shown
abl
form
trimer
shown
indic
mutant
matur
correctli
howev
abil
mutant
mediat
entri
sarspp
serious
decreas
see
figur
introduc
lysin
directli
downstream
aromat
domain
yield
two
fundament
differ
outcom
glycin
replac
lysin
residu
mediat
entri
compar
entri
mediat
swt
indic
charg
residu
could
toler
posit
howev
insert
lysin
residu
result
complet
block
entri
check
whether
phenotyp
result
charg
lysin
alanin
insert
posit
surpris
mutant
also
low
capac
mediat
entri
sarspp
indic
much
charg
lysin
detriment
activ
spike
protein
rather
presenc
extra
amino
acid
posit
introduc
lysin
directli
upstream
cy
box
either
replac
insert
mutant
result
low
entri
activ
indic
posit
charg
lysin
toler
inde
confirm
control
mutant
even
activ
swt
introduct
lysin
posit
result
sever
reduct
fusion
mediat
capac
wherea
mutant
hardli
alter
fusion
mediat
capac
probabl
locat
highli
hydrophob
region
toler
charg
residu
result
mutant
suggest
amino
acid
posit
less
hydrophob
environ
charg
toler
mean
posit
exact
middl
membran
place
charg
residu
toler
likewis
locat
downstream
fourth
cy
residu
cy
box
probabl
membran
sinc
lysin
toler
posit
altogeth
propos
membran
span
domain
sar
start
end
mutagenesi
lysin
insert
show
posit
charg
residu
could
toler
indic
aromat
domain
locat
outsid
membran
inde
hiv
lysin
present
aromat
domain
transmembran
domain
howev
surprisingli
lysin
toler
replac
insert
investig
show
insert
amino
acid
posit
result
nonfunct
protein
suggest
posit
aromat
domain
transmembran
domain
rel
crucial
membran
fusion
activ
sar
fact
mutant
incorpor
sarspp
impli
matur
cy
box
need
enter
hydrophob
environ
howev
support
fusion
suggest
point
fusion
activ
cy
box
suppos
enter
viral
membran
hint
toward
model
long
tmd
dynam
natur
ensur
later
posit
helic
tmd
membran
vari
depend
stage
fusion
process
tryptophan
mutant
sever
crippl
capac
mediat
sarspp
entri
induc
cellcel
fusion
confirm
data
recent
publish
tryptophan
lack
aromat
domain
less
activ
spike
entrymedi
capac
contrast
previous
mutant
f
shown
complet
inact
mutant
wherea
found
approxim
activ
differ
explain
conceiv
singl
mutant
would
exhibit
residu
activ
compar
doubl
tripl
mutant
figur
show
mutant
tryptophan
aromat
domain
unabl
support
entri
sarspp
yet
capabl
initi
membran
fusion
ie
capabl
form
fusion
pore
aromat
domain
hiv
suggest
involv
dilat
fusion
pore
saezcirion
et
al
propos
two
possibl
mechan
tryptophan
residu
might
promot
pore
dilat
first
model
tryptophan
enhanc
transit
two
lipid
stage
fusion
process
second
model
tryptophan
involv
sequest
multipl
molecul
establish
proteinac
ring
therebi
promot
format
fusion
pore
sever
studi
support
lipid
model
sainz
jr
et
al
suggest
conform
chang
spike
aromat
domain
might
align
fusion
peptid
tmd
therebi
function
hydrophob
sheet
allow
lipid
flow
two
fuse
membran
report
shown
peptid
repres
aromat
domain
sar
cov
hiv
membran
activ
capabl
alter
biophys
properti
membran
furthermor
tryptophan
residu
shown
interact
cholesterol
membran
therebi
modul
membran
curvatur
possibl
support
lipid
intermedi
membran
fusion
hiv
sar
cov
also
contain
socal
crac
motif
cholesterol
recognitioninteract
amino
acid
consensu
lv
x
x
rk
locat
upstream
transmembran
domain
might
also
import
membran
fusion
activ
sequest
aromat
domain
support
studi
show
oligomer
hiv
solut
inde
express
bacteria
sar
aromat
domain
form
hexam
solut
j
corver
w
spaan
unpublish
observ
also
shown
sar
cov
entri
depend
presenc
lipid
raft
known
enrich
cholesterol
argu
import
cholesterol
sar
cov
entri
paper
show
function
aromat
domain
sar
cov
similar
function
hiv
aromat
domain
evidenc
phenotyp
featur
mutant
lack
tryptophan
residu
replac
tryptophan
phenylalanin
residu
result
complet
block
fusion
figur
suggest
interfaci
tryptophan
import
also
featur
addit
found
distanc
aromat
domain
tmd
critic
sinc
insert
one
amino
acid
result
block
entri
suggest
posit
aromat
domain
rel
hydrophob
domain
crucial
membran
fusion
activ
featur
yet
includ
model
tri
explain
role
aromat
domain
membran
fusion
activ
coronavirus
therefor
like
propos
model
new
characterist
ad
base
result
describ
result
publish
other
propos
mechan
later
flexibl
aromat
domain
tmd
domain
cy
box
domain
pivot
entri
membran
fusion
activ
sarspp
like
also
sar
cov
model
compris
follow
step
see
figur
nativ
matur
spike
protein
aromat
domain
fold
ectodomain
spike
previous
shown
aromat
domain
nativ
prefus
alreadi
associ
interfac
viral
membran
form
feet
glycoprotein
trimer
tripod
howev
spike
sar
cov
show
typic
feet
tripod
like
structur
therefor
possibl
posit
aromat
domain
sar
cov
differ
nativ
conform
hiv
hydrophob
central
tmd
membran
cy
box
outsid
membran
close
associ
membran
palmit
acid
ii
activ
spike
refold
initi
fusion
fold
back
form
six
helix
bundl
result
aromat
domain
becom
associ
membran
interfac
tryptophan
residu
therebi
pull
hydrophob
core
tmd
thu
iii
pull
cy
box
partial
becom
transmembranelik
domain
releas
aromat
domain
oligomer
consequ
protein
cluster
aromat
domain
oligomer
also
result
cluster
cholesterol
membran
therebi
induc
bend
membran
neg
curvatur
group
protein
induc
oligomer
aromat
domain
would
also
necessari
establish
pore
dilat
ie
transit
pore
real
fusion
event
enabl
larg
molecul
pass
final
shown
previous
glycin
present
hydrophob
central
domain
sar
cov
also
play
import
role
entri
possibl
mediat
bend
tmd
need
membran
fusion
pore
format
bend
central
hydrophob
helix
would
fit
propos
model
enabl
posit
central
domain
lipid
intermedi
stage
stalk
fusion
pore
base
result
paper
conclud
aromat
rich
region
sar
cov
viru
protein
play
crucial
role
entri
sar
cov
like
indic
model
aromat
rich
region
involv
pore
dilat
possibl
interact
cholesterol
modul
membran
curvatur
could
support
lipid
intermedi
membran
fusion
model
propos
presenc
aromat
domain
cystein
rich
domain
ensur
later
flexibl
protein
within
membran
necessari
induct
membran
fusion
process
posit
aromat
domain
downstream
amino
acid
rel
anoth
crucial
prerequisit
entri
process
sar
cov
cell
obtain
atcc
cultur
dmem
fc
cell
kind
gift
dr
adm
osterhau
cultur
dmem
fc
sar
cov
strain
frankfurt
kind
gift
dr
hf
rabenau
hw
doerr
plasmid
encod
sar
spike
phcmvss
describ
plasmid
encod
mutant
spike
protein
creat
use
quikchang
method
stratagen
product
verifi
sequenc
product
sarspp
essenti
carri
describ
briefli
transfect
cell
set
retrovir
gag
pol
express
construct
gfp
report
plasmid
sar
cov
spike
mutant
express
carri
use
transfect
kit
clontech
two
day
transfect
supernat
harvest
use
transduc
cell
correct
amount
retrovir
particl
per
transduct
ctype
revers
transcriptas
activ
kit
innovagen
sweden
use
four
day
transduct
percentag
gfp
posit
cell
determin
fac
analysi
fac
calibur
bectondickinson
cellcel
fusion
measur
sever
assay
basi
assay
readout
differ
immunofluoresc
dye
transfer
assay
cell
transfect
use
lipofectamin
invitrogen
plasmid
encod
sar
mutant
sar
cov
receptor
twenti
four
hour
post
transfect
cell
trypsin
mix
plate
cover
slip
hour
incub
assay
perform
three
differ
assay
immunofluoresc
assay
ifa
dyetransf
assay
cytoplasm
mix
assay
ifa
cell
mix
ratio
vs
respect
fix
paraformaldehyd
permeabil
triton
subsequ
cell
incub
goat
anti
antibodi
r
system
next
cell
incub
fitc
conjug
swineanti
rabbit
antibodi
sigma
hoechst
cell
incub
rabbitanti
spike
antibodi
kind
gift
dr
eickmann
conjug
rabbitanti
goat
antibodi
final
cell
wash
mount
studi
use
fluororesc
microscop
zeiss
dye
transfer
assay
trypsin
transfect
cell
wash
pb
resuspend
optimem
invitrogen
subsequ
calcein
molecular
probe
invitrogen
ad
express
cell
final
concentr
cmac
molecular
probe
invitrogen
ad
express
cell
final
concentr
cell
incub
minut
resuspend
everi
minut
subsequ
media
refresh
cell
transfer
clean
tube
minut
incub
cell
mix
ratio
vs
express
cell
respect
cell
seed
coat
microscop
slide
clearcel
cellin
eri
scientif
compani
hour
incub
cell
fix
paraformaldehyd
analyz
use
fluoresc
microscop
zeiss
cytoplasm
mix
assay
cell
label
cmfda
invitrogen
describ
cmac
mix
stransfect
cell
label
cmtpx
invitrogen
describ
cmac
ratio
cell
cell
cell
respect
hour
incub
cell
fix
paraformaldehyd
analyz
fluoresc
microscopi
sar
sever
acut
respiratori
syndrom
cov
coronaviru
ace
angiotensin
convert
enzym
fc
fetal
calf
serum
dmem
dulbecco
modifi
eagl
medium
fitc
fluorescein
isothiocyan
ifa
immuno
fluoresc
assay
fac
fluorescenceactiv
cell
sort
spike
sarspp
sar
pseudoparticl
tmd
tran
membran
domain
hiv
human
immunodefici
viru
author
declar
compet
interest
design
concept
studi
jc
ws
rb
experiment
work
jc
rb
pvk
write
manuscript
jc
author
read
approv
final
manuscript
